Harbor Investment Advisory’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Other funds holding PBE
YIA
IFWM
PIM
BEI
NDSI
FFA
RA
IHL
KAS
Harbor Investment Advisory's PBE Position: Q2 2026 in Review
Harbor Investment Advisory held its Invesco Biotechnology & Genome ETF (PBE) position steady in Q2 2026 at 150 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1012.
Harbor Investment Advisory first reported a position in PBE in Q4 2019 and has held it in 27 quarters since. The position peaked at $105K in Q4 2025. 31 funds tracked by Wall St. Rank hold PBE as of Q2 2026.
- Harbor Investment Advisory held 150 shares of Invesco Biotechnology & Genome ETF worth $13.4K as of Q2 2026.
- Harbor Investment Advisory left its Invesco Biotechnology & Genome ETF share count unchanged in Q2 2026.
- Invesco Biotechnology & Genome ETF made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #1012 holding.
- Harbor Investment Advisory first reported a position in Invesco Biotechnology & Genome ETF in Q4 2019 and has held it in 27 quarters since.
- Harbor Investment Advisory's Invesco Biotechnology & Genome ETF position peaked at $105K in Q4 2025.
- 31 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2026.
Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.